Hi siamesekitty, what a coincidence to meet you here. I was long on SNTS, I am long on BLRX and I am long on PTIE and DRRX.
I think DRRX at given PPS level is a very attractive investment target, multiple pipline products in late stage (PTIE/Remoxy had two CRLs but is now in the final step to seek and get approval with PFE), and Posidur is a great product for me.
So indeed, DRRX has now at given market cap an outstanding risk:reward ratio. The downside is limited I think, the upside - given Remoxy approval and Posidur partnered and approved - beyond 4 usd.